Beer Marc D
Insider CIK 1314575 · AEGR Chief Executive Officer, Director · NERV Director · BTMD Executive Chairman, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BTMD biote Corp. | P Buy | 2026-08-11 | 2026-08-12 | 16,000 | $1.55 | $24.8K | 239,744 | SEC↗ |
| BTMD biote Corp. | P Buy | 2026-08-11 | 2026-08-12 | 16,000 | $1.55 | $24.8K | 239,744 | SEC↗ |
| BTMD biote Corp. | P Buy | 2026-08-10 | 2026-08-12 | 115,950 | $1.53 | $177.4K | 223,744 | SEC↗ |
| BTMD biote Corp. | P Buy | 2026-08-10 | 2026-08-12 | 115,950 | $1.53 | $177.4K | 223,744 | SEC↗ |
| BTMD biote Corp. | A Award deriv | 2026-06-08 | 2026-06-10 | 114,157 | — | $0 | 114,157 | SEC↗ |
| BTMD biote Corp. | A Award deriv | 2026-05-12 | 2026-05-13 | 195,000 | — | $0 | 195,000 | SEC↗ |
| BTMD biote Corp. | A Award deriv | 2025-04-01 | 2025-04-02 | 495,600 | — | $0 | 495,600 | SEC↗ |
| BTMD biote Corp. | P Buy | 2025-03-17 | 2025-03-18 | 107,794 | $3.87 | $417.2K | 107,794 | SEC↗ |
| BTMD biote Corp. | A Award deriv | 2024-04-01 | 2024-04-03 | 543,958 | — | $0 | 1,338,842 | SEC↗ |
| BTMD biote Corp. | A Award deriv | 2023-05-17 | 2023-05-19 | 317,163 | — | $0 | 794,884 | SEC↗ |
| BTMD biote Corp. | S Sale | 2023-01-09 | 2023-01-10 | 865,384 | $3.00 | $2.60M | 0 | SEC↗ |
| BTMD biote Corp. | C Conversion deriv | 2023-01-06 | 2023-01-10 | 865,384 | — | $0 | 2,967,092 | SEC↗ |
| BTMD biote Corp. | C Conversion | 2023-01-06 | 2023-01-10 | 865,384 | — | $0 | 865,384 | SEC↗ |
| BTMD biote Corp. | J Other | 2023-01-06 | 2023-01-10 | 865,384 | — | $0 | 2,967,092 | SEC↗ |
| BTMD biote Corp. | A Award deriv | 2022-11-15 | 2022-11-16 | 477,721 | — | $0 | 477,721 | SEC↗ |
| BTMD biote Corp. | A Award deriv | 2022-11-15 | 2022-11-18 | 477,721 | — | $0 | 477,721 | SEC↗ |
| BTMD biote Corp. | J Other deriv | 2022-05-26 | 2022-09-19 | 654,387 | — | $0 | 3,832,476 | SEC↗ |
| BTMD biote Corp. | J Other | 2022-05-26 | 2022-09-19 | 654,387 | — | $0 | 3,832,476 | SEC↗ |
| BTMD biote Corp. | A Award deriv | 2022-05-26 | 2022-05-31 | 3,178,089 | — | $0 | 3,178,089 | SEC↗ |
| BTMD biote Corp. | J Other deriv | 2022-05-26 | 2022-05-31 | 654,387 | — | $0 | 3,832,769 | SEC↗ |
| BTMD biote Corp. | A Award | 2022-05-26 | 2022-05-31 | 3,178,089 | — | $0 | 3,178,089 | SEC↗ |
| BTMD biote Corp. | J Other | 2022-05-26 | 2022-05-31 | 654,387 | — | $0 | 3,832,769 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2018-01-31 | 2018-02-02 | 12,500 | — | $0 | 12,500 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2018-01-31 | 2018-02-02 | 12,500 | — | $0 | 12,500 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2018-01-31 | 2018-02-02 | 80,356 | — | $0 | 80,356 | SEC↗ |
| NERV Minerva Neurosciences, Inc | D To issuer deriv | 2018-01-31 | 2018-02-02 | 80,356 | — | $0 | 0 | SEC↗ |
| NERV Minerva Neurosciences, Inc | D To issuer deriv | 2018-01-31 | 2018-02-02 | 12,500 | — | $0 | 0 | SEC↗ |
| NERV Minerva Neurosciences, Inc | D To issuer deriv | 2018-01-31 | 2018-02-02 | 127,513 | — | $0 | 0 | SEC↗ |
| NERV Minerva Neurosciences, Inc | D To issuer deriv | 2018-01-31 | 2018-02-02 | 12,500 | — | $0 | 0 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2018-01-31 | 2018-02-02 | 7,500 | — | $0 | 7,500 | SEC↗ |
| NERV Minerva Neurosciences, Inc | D To issuer deriv | 2018-01-31 | 2018-02-02 | 7,500 | — | $0 | 0 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2018-01-31 | 2018-02-02 | 127,513 | — | $0 | 127,513 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2017-06-01 | 2017-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2017-03-20 | 2017-03-21 | 25,000 | $7.89 | $197.3K | 50,000 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2017-03-17 | 2017-03-21 | 25,000 | $8.34 | $208.5K | 25,000 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2016-06-16 | 2016-06-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-04-01 | 2015-04-03 | 33,000 | — | $0 | 33,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-04-01 | 2015-04-03 | 133,000 | — | $0 | 133,000 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2015-02-02 | 2015-04-16 | 7,500 | — | $0 | 7,500 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2015-02-02 | 2015-02-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2014-12-31 | 2015-01-05 | 120,000 | — | $0 | 120,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | G Gift | 2014-08-28 | 2014-09-02 | 769 | — | $0 | 78,631 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2014-07-31 | 2014-07-31 | 2,300 | $34.37 | $79.1K | 79,400 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2014-07-31 | 2014-07-31 | 7,700 | $33.44 | $257.5K | 77,100 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2014-06-30 | 2014-07-09 | 127,513 | — | $0 | 127,513 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2014-06-03 | 2014-06-04 | 10,000 | $30.12 | $301.2K | 69,400 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2014-05-27 | 2014-05-27 | 10,000 | $31.59 | $315.9K | 59,400 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2014-05-21 | 2014-05-22 | 6,400 | — | $0 | 732,873 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2014-05-21 | 2014-05-22 | 6,400 | $1.54 | $9.9K | 49,400 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2014-05-20 | 2014-05-21 | 10,000 | $30.53 | $305.3K | 43,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2014-05-08 | 2014-05-08 | 30,000 | $35.31 | $1.06M | 33,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2014-04-01 | 2014-04-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2014-03-26 | 2014-03-27 | 3,000 | — | $0 | 739,273 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2014-03-26 | 2014-03-27 | 3,000 | $1.54 | $4.6K | 3,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-12-04 | 2013-12-06 | 4,380 | — | $0 | 742,273 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-12-04 | 2013-12-06 | 4,380 | $1.54 | $6.7K | 4,380 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | G Gift | 2013-12-04 | 2013-12-06 | 4,380 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-11-05 | 2013-11-06 | 39,000 | — | $0 | 746,653 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-11-05 | 2013-11-06 | 39,000 | $1.54 | $60.1K | 234,726 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-10-30 | 2013-10-31 | 40,000 | — | $0 | 785,653 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-30 | 2013-10-31 | 3,800 | $89.01 | $338.2K | 203,726 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-30 | 2013-10-31 | 6,019 | $87.83 | $528.6K | 207,526 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-30 | 2013-10-31 | 10,000 | $87.08 | $870.8K | 213,545 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-30 | 2013-10-31 | 2,314 | $85.94 | $198.9K | 223,545 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-30 | 2013-10-31 | 7,067 | $85.00 | $600.7K | 225,859 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-30 | 2013-10-31 | 2,800 | $84.15 | $235.6K | 232,926 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-10-30 | 2013-10-31 | 40,000 | $1.54 | $61.6K | 235,726 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-30 | 2013-10-31 | 2,700 | $89.85 | $242.6K | 201,026 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-30 | 2013-10-31 | 200 | $94.25 | $18.9K | 197,226 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-30 | 2013-10-31 | 2,500 | $91.21 | $228.0K | 198,526 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-30 | 2013-10-31 | 1,200 | $99.18 | $119.0K | 195,726 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-30 | 2013-10-31 | 300 | $95.90 | $28.8K | 196,926 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-30 | 2013-10-31 | 700 | $92.03 | $64.4K | 197,826 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-10-30 | 2013-10-31 | 400 | $93.00 | $37.2K | 197,426 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | G Gift | 2013-09-03 | 2013-09-06 | 3,335 | — | $0 | 195,726 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise deriv | 2013-08-15 | 2013-08-16 | 60,000 | — | $0 | 825,653 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | M Exercise | 2013-08-15 | 2013-08-16 | 60,000 | $1.54 | $92.4K | 259,061 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-08-15 | 2013-08-16 | 12,301 | $88.21 | $1.09M | 226,596 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-08-15 | 2013-08-16 | 6,275 | $89.09 | $559.0K | 220,321 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-08-15 | 2013-08-16 | 21,160 | $89.95 | $1.90M | 199,161 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-08-15 | 2013-08-16 | 100 | $90.72 | $9.1K | 199,061 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | S Sale | 2013-08-15 | 2013-08-16 | 20,164 | $87.08 | $1.76M | 238,897 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2013-04-01 | 2013-04-03 | 105,000 | — | $0 | 105,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2012-03-29 | 2012-03-30 | 1,000 | $13.74 | $13.7K | 199,061 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | P Buy | 2012-03-22 | 2012-03-23 | 1,000 | $13.96 | $14.0K | 198,061 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2012-02-01 | 2012-02-09 | 85,000 | — | $0 | 85,000 | SEC↗ |